{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:05:17Z","timestamp":1780092317322,"version":"3.54.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"crossref","award":["MRFF2017156"],"award-info":[{"award-number":["MRFF2017156"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Propofol is a widely used anesthetic agent, yet it exhibits substantial interindividual variability in dosage requirements\u2014likely driven by pharmacokinetic and\/or pharmacodynamic factors. Despite ongoing efforts, accurate population-based pharmacokinetic\u2013pharmacodynamic dosing algorithms, targeting plasma propofol concentrations, remain suboptimal. Reliable, high throughput and cost-efficient bioanalytical methods are required to quantify plasma propofol concentrations in large-scale clinical pharmacokinetic\u2013pharmacodynamic studies to improve these algorithms. A review of the existing literature indicated an absence of liquid chromatography - tandem mass spectrometry (LC-MS\/MS) assays suitable for this purpose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The authors developed, optimized, validated, and clinically applied a new bioanalytical method using protein precipitation and LC-MS\/MS quantification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The assay demonstrated intra- and inter-run assay accuracy of 86%\u2013114% and 94%\u2013105%, respectively, across the quantification range of 25\u20135000 ng\/mL. Intra- and inter-run coefficients of variation were 2.7%\u201315.7% and 1.1%\u20135.0%, respectively. Propofol extraction recovery was 92%, with a total run-time of 5.5 minutes. This method demonstrated acceptable performance for dilution integrity, matrix effects, and stability under bench-top, freeze\u2013thaw, autosampler, and long-term storage conditions, as well as reinjection reproducibility. This method was subsequently applied to quantify plasma propofol concentrations in a patient undergoing major noncardiac surgery, assessing the corresponding concentration\u2013time profile. All measured propofol concentrations (648\u20134356 ng\/mL) were within the validated assay quantification range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The authors report a robust and efficient LC\u2013MS\/MS assay for propofol that was optimized, validated, and shown to be suitable for large-scale clinical pharmacokinetic studies. This fit-for-purpose method supports population pharmacokinetic modelling to inform more individualized dosing strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001474","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:00:09Z","timestamp":1780092009000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Development and Application of an LC-MS\/MS Assay for Plasma Propofol Quantification in Major Noncardiac Surgical Patients to Evaluate Target-Controlled Infusion Algorithms"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3094-9236","authenticated-orcid":false,"given":"Matthew K. L.","family":"Ng","sequence":"first","affiliation":[{"name":"Discipline of Pharmacology, School of Pharmacy and Biomedical Science, College of Health, Adelaide University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan T.","family":"Musolino","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology, School of Pharmacy and Biomedical Science, College of Health, Adelaide University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Barratt","sequence":"additional","affiliation":[{"name":"Discipline of Physiology, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Gerstman","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Perioperative Medicine, and Pain Medicine, Peter MacCallum Cancer Centre;"},{"name":"The Sir Peter MacCallum Department of Oncology, University of Melbourne;"},{"name":"Department of Critical Care, University of Melbourne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Riedel","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Perioperative Medicine, and Pain Medicine, Peter MacCallum Cancer Centre;"},{"name":"The Sir Peter MacCallum Department of Oncology, University of Melbourne;"},{"name":"Department of Critical Care, University of Melbourne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl M.","family":"Kirkpatrick","sequence":"additional","affiliation":[{"name":"Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Somogyi","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacology, School of Pharmacy and Biomedical Science, College of Health, Adelaide University;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"R1-20260529","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1476-5381.1991.tb12479.x","article-title":"The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones","volume":"104","author":"Hales","year":"1991","journal-title":"Br J Pharmacol"},{"key":"R2-20260529","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/bja\/88.5.653","article-title":"Propofol metabolites in man following propofol induction and maintenance","volume":"88","author":"Favetta","year":"2002","journal-title":"Br J Anaesth"},{"key":"R3-20260529","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1213\/00000539-198712000-00010","article-title":"Disposition of propofol administered as constant rate intravenous infusions in humans","volume":"66","author":"Gepts","year":"1987","journal-title":"Anesth Analgesia"},{"key":"R4-20260529","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"R6-20260529","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bja.2025.05.036","article-title":"Impact of genetic variations on the pharmacokinetics, dose requirements, and clinical effects of propofol: a systematic review","volume":"135","author":"Gerstman","year":"2025","journal-title":"Br J Anaesth"},{"key":"R7-20260529","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bja\/67.1.41","article-title":"Pharmacokinetic model driven infusion of propofol in children","volume":"67","author":"Marsh","year":"1991","journal-title":"Br J Anaesth"},{"key":"R8-20260529","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00000542-199805000-00006","article-title":"The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers","volume":"88","author":"Schnider","year":"1998","journal-title":"Anesthesiology"},{"key":"R9-20260529","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00000542-200308000-00014","article-title":"Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics","volume":"99","author":"Minto","year":"2003","journal-title":"Anesthesiology"},{"key":"R10-20260529","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/ACO.0000000000001529","article-title":"The future of target-controlled infusion and new pharmacokinetic models","volume":"38","author":"Absalom","year":"2025","journal-title":"Curr Opin Anaesthesiol"},{"key":"R11-20260529","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/bja\/aem294","article-title":"Inter-individual variability in propofol pharmacokinetics in preterm and term neonates","volume":"99","author":"Allegaert","year":"2007","journal-title":"Br J Anaesth"},{"key":"R12-20260529","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1038\/s41598-024-56863-z","article-title":"Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations","volume":"14","author":"Kawata","year":"2024","journal-title":"Scientific Rep"},{"key":"R13-20260529","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00000542-200003000-00017","article-title":"Population pharmacokinetics of propofol: a multicenter study","volume":"92","author":"Sch\u00fcttler","year":"2000","journal-title":"Anesthesiology"},{"key":"R14-20260529","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ALN.0b013e3181b799c1","article-title":"Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate","volume":"111","author":"Masui","year":"2009","journal-title":"Anesthesiology"},{"key":"R15-20260529","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/bja\/aex007","article-title":"Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia","volume":"118","author":"Hara","year":"2017","journal-title":"Br J Anaesth"},{"key":"R16-20260529","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/bja\/aeq195","article-title":"Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model","volume":"105","author":"Cort\u00ednez","year":"2010","journal-title":"Br J Anaesth"},{"key":"R17-20260529","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/ALN.0b013e31821a8d80","article-title":"An evaluation of using population pharmacokinetic models to estimate pharmacodynamic parameters for propofol and bispectral index in children","volume":"115","author":"Coppens","year":"2011","journal-title":"Anesthesiology"},{"key":"R18-20260529","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/bja\/65.2.177","article-title":"Pharmacokinetics of propofol infusions in patients with cirrhosis","volume":"65","author":"Servin","year":"1990","journal-title":"Br J Anaesth"},{"key":"R19-20260529","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/72.3.302","article-title":"A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients","volume":"72","author":"Short","year":"1994","journal-title":"Br J Anaesth"},{"key":"R20-20260529","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1213\/ane.0b013e31819e4058","article-title":"Mixed-effects modeling of the influence of Midazolam on propofol pharmacokinetics","volume":"108","author":"Vuyk","year":"2009","journal-title":"Anesth Analgesia"},{"key":"R21-20260529","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00003088-200847020-00005","article-title":"Use of target controlled infusion to derive age and gender covariates for propofol clearance","volume":"47","author":"White","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R22-20260529","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2012.05.011","article-title":"Comparison of GC\/MS and LC\/MS methods for the analysis of propofol and its metabolites in urine","volume":"900","author":"Lee","year":"2012","journal-title":"J Chromatogr B Anal Tech Biomed Life Sci"},{"key":"R23-20260529","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10877-021-00738-5","article-title":"Propofol detection for monitoring of intravenous anaesthesia: a review","volume":"36","author":"Ferrier","year":"2022","journal-title":"J Clin Monit Comput"},{"key":"R24-20260529","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4323\/rjlm.2011.145","article-title":"High-throughput toxicological analysis of propofol in human whole blood by LC-MS","volume":"19","author":"Vlase","year":"2011","journal-title":"Rom J Leg Med"},{"key":"R25-20260529","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4155\/bio.15.89","article-title":"Quantification of remifentanil and propofol in human plasma: a LC\u2013MS\/MS assay validated according to the EMA guideline","volume":"7","author":"Alvarez","year":"2015","journal-title":"Bioanalysis"},{"key":"R26-20260529","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1570-0232(04)00661-0","article-title":"A new method for the quantitation of propofol in human plasma: efficient solid-phase extraction and liquid chromatography\/APCI-triple quadrupole mass spectrometry detection","volume":"810","author":"Bajpai","year":"2004","journal-title":"J Chromatogr B Anal Tech Biomed Life Sci"},{"key":"R27-20260529","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jpba.2005.04.041","article-title":"Development of a rapid and sensitive LC\u2013ESI\/MS\/MS assay for the quantification of propofol using a simple off-line dansyl chloride derivatization reaction to enhance signal intensity","volume":"39","author":"Beaudry","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"R28-20260529","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchromb.2007.04.021","article-title":"Quantitative measurement of propofol and in main glucuroconjugate metabolites in human plasma using solid phase extraction\u2013liquid chromatography\u2013tandem mass spectrometry","volume":"854","author":"Cohen","year":"2007","journal-title":"J Chromatogr B Anal Tech Biomed Life Sci"},{"key":"R29-20260529","doi-asserted-by":"crossref","first-page":"113521","DOI":"10.1016\/j.jpba.2020.113521","article-title":"Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the simultaneous quantification of five analgesics and sedatives, and six of their active metabolites in human plasma: application to a clinical study on the determination of neurological death in the intensive care unit","volume":"190","author":"Jutras","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"R30-20260529","doi-asserted-by":"crossref","first-page":"462360","DOI":"10.1016\/j.chroma.2021.462360","article-title":"Fluoride-assisted liquid chromatography-tandem mass spectrometry method for simultaneous analysis of propofol and its metabolites without derivatization in urine","volume":"1652","author":"Lee","year":"2021","journal-title":"J Chromatogr A"},{"key":"R31-20260529","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1016\/j.jchromb.2009.10.010","article-title":"Formation of the N-methylpyridinium ether derivative of propofol to improve sensitivity, specificity and reproducibility of its detection in blood by liquid chromatography\u2013mass spectrometry","volume":"877","author":"Thieme","year":"2009","journal-title":"J Chromatogr B Anal Tech Biomed Life Sci"},{"key":"R32-20260529","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1007\/s00216-013-7573-y","article-title":"Enhancing the sensitivity of the LC-MS\/MS detection of propofol in urine and blood by azo-coupling derivatization","volume":"406","author":"Vaiano","year":"2014","journal-title":"Anal Bioanal Chem"},{"key":"R33-20260529","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpba.2016.11.051","article-title":"Liquid chromatography-tandem mass spectrometric determination of propofol in rat serum and hair at attogram level after derivatization with 3-bromomethyl-propyphenazone","volume":"134","author":"Khedr","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"R34-20260529","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00216-016-0086-8","article-title":"1,2-Dimethylimidazole-4-sulfonyl chloride (DMISC), a novel derivatization strategy for the analysis of propofol by LC-ESI-MS\/MS","volume":"409","author":"Maas","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"R35-20260529","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jpba.2017.12.043","article-title":"Design and validation of an automated solid phase extraction liquid chromatography coupled mass spectrometry method for the quantification of propofol in plasma","volume":"150","author":"Maurer","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"R36-20260529","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00000542-199507000-00003","article-title":"The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women","volume":"83","author":"Vuyk","year":"1995","journal-title":"Anesthesiology"},{"key":"R37-20260529","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000542-199410000-00008","article-title":"The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision","volume":"81","author":"Smith","year":"1994","journal-title":"Anesthesiology"},{"key":"R39-20260529","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chroma.2015.05.010","article-title":"Ammonium fluoride as a mobile phase additive in aqueous normal phase chromatography","volume":"1401","author":"Pesek","year":"2015","journal-title":"J Chromatogr A"},{"key":"R40-20260529","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jasms.2005.02.009","article-title":"Mass spectral fragmentation of the intravenous anesthetic propofol and structurally related phenols","volume":"16","author":"Bajpai","year":"2005","journal-title":"J Am Soc MA Spectrom"},{"key":"R41-20260529","first-page":"1114","article-title":"The study and application of analyte adduct based ionisation of propofol in the analysis with liquid chromatography-tandem mass spectrometry","author":"Dziadosz","year":"2019","journal-title":"J Chromatogr B Anal Tech Biomed Life Sci"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:00:14Z","timestamp":1780092014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001474","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2025-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}